Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine.

Source:http://linkedlifedata.com/resource/pubmed/id/15173014

Cancer Res. 2004 Jun 1 64 11 4001-9

Download in:

View as

General Info

PMID
15173014